These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 35136034)

  • 1. Sox2 induces glioblastoma cell stemness and tumor propagation by repressing TET2 and deregulating 5hmC and 5mC DNA modifications.
    Lopez-Bertoni H; Johnson A; Rui Y; Lal B; Sall S; Malloy M; Coulter JB; Lugo-Fagundo M; Shudir S; Khela H; Caputo C; Green JJ; Laterra J
    Signal Transduct Target Ther; 2022 Feb; 7(1):37. PubMed ID: 35136034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Sox2:miR-486-5p Axis Regulates Survival of GBM Cells by Inhibiting Tumor Suppressor Networks.
    Lopez-Bertoni H; Kotchetkov IS; Mihelson N; Lal B; Rui Y; Ames H; Lugo-Fagundo M; Guerrero-Cazares H; Quiñones-Hinojosa A; Green JJ; Laterra J
    Cancer Res; 2020 Apr; 80(8):1644-1655. PubMed ID: 32094299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TET2-Mediated Spatiotemporal Changes of 5-Hydroxymethylcytosine During Organogenesis in the Late Mouse Fetus.
    Li X; Xie F; Jin J; Wu Y; Luo Z; Zhang F; Zhang S; Chen D; Liu A
    Anat Rec (Hoboken); 2019 Jun; 302(6):954-963. PubMed ID: 30369084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TET2 regulates extranodal NK/T cell lymphoma progression through regulation of DNA methylation.
    Xiang C; Gao L; Tao Q; Chen Z; Zhao S; Liu W
    Hematol Oncol; 2024 Jul; 42(4):e3295. PubMed ID: 38979860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiR-10b-5p Impairs TET2-Mediated Inhibition of PD-L1 Transcription Thus Promoting Immune Evasion and Tumor Progression in Glioblastoma.
    Du W; Chen D; Wei K; Yu D; Gan Z; Xu G; Yao G
    Tohoku J Exp Med; 2023 Jul; 260(3):205-214. PubMed ID: 37019647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MYC deregulates TET1 and TET2 expression to control global DNA (hydroxy)methylation and gene expression to maintain a neoplastic phenotype in T-ALL.
    Poole CJ; Lodh A; Choi JH; van Riggelen J
    Epigenetics Chromatin; 2019 Jul; 12(1):41. PubMed ID: 31266538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct and overlapping control of 5-methylcytosine and 5-hydroxymethylcytosine by the TET proteins in human cancer cells.
    Putiri EL; Tiedemann RL; Thompson JJ; Liu C; Ho T; Choi JH; Robertson KD
    Genome Biol; 2014 Jun; 15(6):R81. PubMed ID: 24958354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flanking sequences influence the activity of TET1 and TET2 methylcytosine dioxygenases and affect genomic 5hmC patterns.
    Adam S; Bräcker J; Klingel V; Osteresch B; Radde NE; Brockmeyer J; Bashtrykov P; Jeltsch A
    Commun Biol; 2022 Jan; 5(1):92. PubMed ID: 35075236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct roles of the methylcytosine oxidases Tet1 and Tet2 in mouse embryonic stem cells.
    Huang Y; Chavez L; Chang X; Wang X; Pastor WA; Kang J; Zepeda-Martínez JA; Pape UJ; Jacobsen SE; Peters B; Rao A
    Proc Natl Acad Sci U S A; 2014 Jan; 111(4):1361-6. PubMed ID: 24474761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic downregulation of TET3 reduces genome-wide 5hmC levels and promotes glioblastoma tumorigenesis.
    Carella A; Tejedor JR; García MG; Urdinguio RG; Bayón GF; Sierra M; López V; García-Toraño E; Santamarina-Ojeda P; Pérez RF; Bigot T; Mangas C; Corte-Torres MD; Sáenz-de-Santa-María I; Mollejo M; Meléndez B; Astudillo A; Chiara MD; Fernández AF; Fraga MF
    Int J Cancer; 2020 Jan; 146(2):373-387. PubMed ID: 31211412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early Expression of Tet1 and Tet2 in Mouse Zygotes Altered DNA Methylation Status and Affected Embryonic Development.
    Qi Q; Wang Q; Liu K; Bian J; Yu Z; Hou J
    Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35955629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of high 5-hydroxymethylcytosine levels with Ten Eleven Translocation 2 overexpression and inflammation in Sjögren's syndrome patients.
    Lagos C; Carvajal P; Castro I; Jara D; González S; Aguilera S; Barrera MJ; Quest AFG; Bahamondes V; Molina C; Urzúa U; Hermoso MA; Leyton C; González MJ
    Clin Immunol; 2018 Nov; 196():85-96. PubMed ID: 29894742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TET2 Drives 5hmc Marking of GATA6 and Epigenetically Defines Pancreatic Ductal Adenocarcinoma Transcriptional Subtypes.
    Eyres M; Lanfredini S; Xu H; Burns A; Blake A; Willenbrock F; Goldin R; Hughes D; Hughes S; Thapa A; Vavoulis D; Hubert A; D'Costa Z; Sabbagh A; Abraham AG; Blancher C; Jones S; Verrill C; Silva M; Soonawalla Z; Maughan T; Schuh A; Mukherjee S; O'Neill E
    Gastroenterology; 2021 Aug; 161(2):653-668.e16. PubMed ID: 33915173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TET2 is a component of the estrogen receptor complex and controls 5mC to 5hmC conversion at estrogen receptor cis-regulatory regions.
    Broome R; Chernukhin I; Jamieson S; Kishore K; Papachristou EK; Mao SQ; Tejedo CG; Mahtey A; Theodorou V; Groen AJ; D'Santos C; Balasubramanian S; Farcas AM; Siersbæk R; Carroll JS
    Cell Rep; 2021 Feb; 34(8):108776. PubMed ID: 33626359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural insight into substrate preference for TET-mediated oxidation.
    Hu L; Lu J; Cheng J; Rao Q; Li Z; Hou H; Lou Z; Zhang L; Li W; Gong W; Liu M; Sun C; Yin X; Li J; Tan X; Wang P; Wang Y; Fang D; Cui Q; Yang P; He C; Jiang H; Luo C; Xu Y
    Nature; 2015 Nov; 527(7576):118-22. PubMed ID: 26524525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The expression of TET3 regulated cell proliferation in HepG2 cells.
    Zhong X; Liu D; Hao Y; Li C; Hao J; Lin C; Shi S; Wang D
    Gene; 2019 May; 698():113-119. PubMed ID: 30836118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic modulation of a miR-296-5p:HMGA1 axis regulates Sox2 expression and glioblastoma stem cells.
    Lopez-Bertoni H; Lal B; Michelson N; Guerrero-Cázares H; Quiñones-Hinojosa A; Li Y; Laterra J
    Oncogene; 2016 Sep; 35(37):4903-13. PubMed ID: 26898758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic silencing of TET2 and TET3 induces an EMT-like process in melanoma.
    Gong F; Guo Y; Niu Y; Jin J; Zhang X; Shi X; Zhang L; Li R; Chen L; Ma RZ
    Oncotarget; 2017 Jan; 8(1):315-328. PubMed ID: 27852070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-196a promotes the proliferation and migration of esophageal cancer via the UHRF2/TET2 axis.
    Hu CM; Peng J; Lv L; Wang XH; Huo JR; Liu DL
    Mol Cell Biochem; 2022 Feb; 477(2):537-547. PubMed ID: 34826027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Values of 5mC, 5hmC, and TET2 for identifying the presence and progression of breast precancerous lesion.
    Zhang Z; Jin Y; Zhang W; Chu C; Zhang K; Gao X; Zhou J; Zou L; Tang F; Wang H; Zou Q
    J Clin Lab Anal; 2020 May; 34(5):e23162. PubMed ID: 31867779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.